Mylan Institutional, Inc. recalls Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per…
Super-Potent Drug: Out of specification potency results were obtained.
Read the official notice →- Date
- 2025-03-26
- Country
- United States
- Brand
- Mylan Institutional
- Product
- Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per…
- Classification
- Class II
- Units
- Nationwide in the USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More Mylan Institutional recalls
- 2024-12-18
US- 2022-05-18
- US
Mylan Institutional, Inc. (d.b.a. UDL Laboratories) recalls Esomeprazole Magnesium Delayed-Release Capsules, USP 20 mg, packaged in Unit Dose Blister Cards of 6 (10…
Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.
Other drugs & medical recalls in the United States
- 2025-03-26
- US
MEDLINE INDUSTRIES, LP - Northfield recalls Proxima Drape labeled as PACK,BASIC,SIRUS,V,5/CS; PACK,BASIC IV,SIRUS,5/CS; PACK,SET UP,NO DRAPE,12/CS; PACK,SET UP,NO…
Potential breach in pouch packaging which could lead to loss of sterility.
- US
American Contract Systems Inc recalls MAJOR VASCULAR PACK , Model No UTMV78X-01 UTMV78Y UTMV78Y-01 UTMV78X-01 UTMV78Y-02
ACS is unable to confirm product sterilization assurance requirements were met. Possible loss or lack of functionality may lead to delay or prolonged treatment.
FDA · DeviceAmerican Contract Systems IncUS Nationwide distribution in the state of OH.Official notice → - US
Smiths Medical ASD, Inc. recalls smiths medical ProPort Plastic Venous Access System, Implantable Venous Access Systems, 82-24
The plastic port housing and port reservoir of the ProPort Plastic Implantable Ports may separate because of a manufacturing defect.
- US
- US
- US
Amgen, Inc. recalls Neupogen (filgrastim) For Injection, 300mcg/1 mL, 1 mL Single Dose Vials, Rx Only, For Subcutaneous or Intravenous Use Only, Sterile…
Stability data does not support expiry: the products have the potential to be out of specification at the time of expiry of 36-months.
FDA · DrugAmgen, Inc.Nationwide in the U.S.A. and Belgium/Luxembourg, Brazil, Chile, Colombia,…Official notice →